Insider trade

Thermo Fisher Scientific (TMO): CEO had shares withheld for tax 531.85 shares

Marc N Casper, CEO at Thermo Fisher Scientific, reported a tax withholding of 531.85 shares.

531.85
Shares · @ $622.18
Traded
Aug 28, 2026
Filed
Sep 1, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 12, 2024CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  2. Mar 27, 2026Federal contract · $4.5M obligatedDepartment of Commerce awarded Thermo Fisher Scientific: $4.49M obligated to date
  3. Mar 27, 2026CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  4. Jul 10, 2026CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  5. Jul 21, 2026Government · Federal Register noticeGranting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
  6. Jul 23, 2026Company filing · Form 8-K · ResultsReported its results
  7. Jul 24, 2026FDAFDA device clearance: Thermo Scientific Oxoid Cefepime/Zidebactam Disc (30/30 µg) FPZ60
  8. Jul 27, 2026InsiderOfficer sold ~$226K of TMO shares in the open market
  9. Aug 5, 2026Insider · 1 personInsiders: 22 sales (~$8.6M)
  10. Aug 6, 2026Insider · 2 peopleInsiders: 19 sales (~$12.0M)
  11. Aug 7, 2026Insider · 2 peopleInsiders: 28 sales (~$3.1M)
  12. Aug 11, 2026Insider · 1 personInsiders: 2 sales (~$15.3M)
  13. Aug 14, 2026FDARecall: Ion Torrent Genexus Dx with software, Catalog: A40003539, which supports the Ion Torrent Genexus Dx Integrated Sequencer
  14. Aug 19, 2026Insider · Their largest sale since 2024Officer sold ~$7.01M of TMO shares in the open market
  15. Aug 20, 2026Insider · 1 personInsiders: 3 sales (~$1.9M)

What came next

  1. Oct 15, 2026FDAFDA device clearance: Oncomine ™ Dx Express Test
  2. Oct 21, 2026Company filing · Form 8-K · ResultsReported its results
  3. Oct 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 27, 2026, Thermo Fisher Scientific Inc. (the “Company”), announced that Michael D. Shafer, Executive Vice President of the Company, will retire effective December 31, 2026. 2”
  4. Nov 5, 20265% stakeFMR LLC reported a passive stake (13G) of 6.0%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Thermo Fisher Scientific

For Thermo Fisher Scientific, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 6 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMO page.

Other recent filings by Marc N Casper, Chairman & CEO

The full history of Marc N Casper, Chairman & CEO is on the profile page.

How this filing works

Explore the data

Common questions

Which Thermo Fisher Scientific (TMO) insider traded, and how much?

Marc N Casper, CEO at Thermo Fisher Scientific, reported a tax withholding of 531.85 shares. At $622.18.

When did it happen, and when was it made public?

Traded: Aug 28, 2026. Filed: Sep 1, 2026. That is 4 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Thermo Fisher Scientific recently?

For Thermo Fisher Scientific, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 6 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the TMO page.

Does this mean TMO stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Thermo Fisher Scientific

Everything OQRO holds on this company is on its TMO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data